frozen cold viking long boat winter snow
Biotech

Viking hits stormy seas as phase 2 oral obesity data sink stock

Viking saw weight loss of up to 12.2%. But with 38% of patients discontinuing treatment at the most effective dose, investors sent the stock down 37%.
Nick Paul Taylor Aug 19, 2025 9:44am
clock delay wait time alarm

Regenxbio's Hunter gene therapy latest to face FDA delay

Aug 19, 2025 10:30am
Investigational Rosnilimab Emerges as a Novel Differentiated Treatment Option for Rheumatoid Arthritis

Investigational Rosnilimab Emerges as a Novel

Aug 18, 2025 8:00am
team layoffs workforce

CSL to lose up to 15% of staff, cut R&D costs, spin out vaccines

Aug 19, 2025 7:06am
Jigsaw pieces

VantAI plays matchmaker for Halda's RIPTACs in $1B deal

Aug 19, 2025 8:00am
end of the road road block shut down closed blocked

FDA snubs PTC's Friedreich's ataxia hopeful with CRL

Aug 19, 2025 10:55am
More News

Medtronic to eye M&A, efficiencies after activist investor stake

Aug 19, 2025 11:26am

Nighttime insulin patch pump maker Luna Diabetes raises $23.6M

Aug 19, 2025 11:21am

Fierce Biotech Layoff Tracker 2025: CSL, Opthea & more

Aug 19, 2025 9:00am

Opthea ramps up cuts to 85% of staff, including CEO

Aug 19, 2025 7:35am